Primary cytomegalovirus infection significantly impacts circulating T cells in kidney transplant recipients

American Journal of Transplantation

Volumn 15, Issue 12, 2015, Pages 3143-3156

  Meijers, R W J ^a   Litjens, N H R ^a   Hesselink, D A ^a   Langerak, A W ^a   Baan, C C ^a   Betjes, M G H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; CD28 ANTIGEN; CD31 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DONOR; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT; MALE; MEMORY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE HOMEOSTASIS; VIREMIA; ADVERSE EFFECTS; CYTOMEGALOVIRUS; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR; VIROLOGY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; VIRUS REPLICATION;

EID: 84948714851     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13396     Document Type: Article

References (43)

1. Derhovanessian E, Larbi A, Pawelec G,. Biomarkers of human immunosenescence: Impact of cytomegalovirus infection. Curr Opin Immunol 2009; 21: 440-445.
2. Litjens NH, de Wit EA, Betjes MG,. Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun Ageing 2011; 8: 2.
3. Meijers RW, Litjens NH, de Wit EA, et al., Cytomegalovirus contributes partly to uremia-associated premature immunological ageing of the T-cell compartment. Clin Exp Immunol 2013; 21: 424-432.
4. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F,. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: The Swedish NONA immune study. Exp Gerontol 2002; 37: 445-453.
5. Weng NP, Akbar AN, Goronzy J,. CD28(-) T cells: Their role in the age-associated decline of immune function. Trends Immunol 2009; 30: 306-312.
6. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG,. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: The Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998; 102: 187-198.
7. Betjes MG, Huisman M, Weimar W, Litjens NH,. Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int 2008; 74: 760-767.
8. Betjes MG, Weimar W, Litjens NH,. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD. J Am Soc Nephrol 2009; 20: 2661-2666.
9. Girndt M, Pietsch M, Kohler H,. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995; 26: 454-460.
10. Litjens NH, Huisman M, van den Dorpel M, Betjes MG,. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008; 19: 1483-1490.
11. Sarnak MJ, Jaber BL,. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764.
12. Stewart JH, Vajdic CM, van Leeuwen MT, et al., The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 2009; 24: 3225-3231.
13. Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG,. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int 2004; 66: 614-621.
14. Betjes MG, de Wit EE, Weimar W, Litjens NH,. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol Dial Transplant 2010; 25: 3640-3646.
15. Betjes MG, Meijers RW, de Wit LE, Litjens NH,. A killer on the road: Circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol 2012; 25: 183-191.
16. Yap M, Boeffard F, Clave E, et al., Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T Cells in a subset of clinically stable kidney transplant recipients: A potential marker for late graft dysfunction. J Am Soc Nephrol 2014; 25: 1856-1868.
17. Wertheimer AM, Bennett MS, Park B, et al., Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 2014; 192: 2143-2155.
18. Leone F, Akl A, Giral M, et al., Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation. Transpl Int 2010; 23: 897-906.
19. Sagedal S, Nordal KP, Hartmann A, et al., The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002; 2: 850-856.
20. Kliem V, Fricke L, Wollbrink T, Burg M, Radermacher J, Rohde F,. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial. Am J Transplant 2008; 8: 975-983.
21. Meijers RW, Litjens NH, de Wit EA, Langerak AW, Baan CC, Betjes MG,. Uremia-associated immunological ageing is stably imprinted in the T-cell system and not reversed by kidney transplantation. Transpl Int 2014; 31: 1272-1284.
22. La Rosa C, Limaye AP, Krishnan A, Blumstein G, Longmate J, Diamond DJ,. Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients. Transpl Int 2011; 24: 920-931.
23. Litjens NH, de Wit EA, Baan CC, Betjes MG,. Activation-induced CD137 is a fast assay for identification and multi-parameter flow cytometric analysis of alloreactive T cells. Clin Exp Immunol 2013; 174: 179-191.
24. Bouvy AP, Kho MM, Klepper M, et al., Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients. Transplantation 2013; 27: 904-913.
25. Betjes MGH, Langerak AW, van der Spek A, de Wit EA, Litjens NHR,. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int 2011; 80: 209-218.
26. Zubakov D, Liu F, van Zelm MC, et al., Estimating human age from T-cell DNA rearrangements. Curr Biol 2010; 20: R970-R971.
27. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM,. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 2006; 1: 2365-2376.
28. Kohler S, Thiel A,. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 2009; 113: 769-774.
29. Courivaud C, Bamoulid J, Chalopin JM, et al., Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J Infect Dis 2013; 207: 1569-1575.
30. Song K, Rabin RL, Hill BJ, et al., Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc Natl Acad Sci USA 2005; 102: 7916-7921.
31. Weinberger B, Lazuardi L, Weiskirchner I, et al., Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68: 86-90.
32. Suessmuth Y, Mukherjee R, Watkins B, et al., CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRbeta repertoire. Blood 2015; 125: 3835-3850.
33. Yadav AK, Kumar V, Jha V,. Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4+CD28null cells in chronic kidney disease. Mediators Inflamm 2013: 384807.
34. Abate D, Saldan A, Fiscon M, et al., Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. J Infect Dis 2010; 202: 585-594.
35. van de Berg PJ, Griffiths SJ, Yong SL, et al., Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 2010; 184: 3417-3423.
36. Price P, Olver SD, Gibbons AE, Teo HK, Shellam GR,. Characterization of thymic involution induced by murine cytomegalovirus infection. Immunol Cell Biol 1993; 71: 155-165.
37. Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM,. Direct infection of CD34+ progenitor cells by human cytomegalovirus: Evidence for inhibition of hematopoiesis and viral replication. Blood 1996; 88: 1277-1283.
38. Erdbruegger U, Scheffner I, Mengel M, et al., Impact of CMV infection on acute rejection and long-term renal allograft function: A systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transplant 2012; 27: 435-443.
39. McLaughlin K, Wu C, Fick G, Muirhead N, Hollomby D, Jevnikar A,. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection. Transplantation 2002; 74: 813-816.
40. Opelz G, Dohler B, Ruhenstroth A,. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 928-936.
41. Dickenmann MJ, Cathomas G, Steiger J, Mihatsch MJ, Thiel G, Tamm M,. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 2001; 71: 764-767.
42. Yadav AK, Jha V,. CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol Dial Transplant 2011; 26: 1689-1694.
43. Christmas SE, Halliday D, Lawton N, et al., Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection. Transpl Immunol 2009; 22: 99-104.